Literature DB >> 28752332

Adverse bone effects of medications used to treat non-skeletal disorders.

N B Watts1.   

Abstract

There is a growing list of medications used to treat non-skeletal disorders that cause bone loss and/or increase fracture risk. This review discusses glucocorticoids, drugs that reduce sex steroids, antidiabetic agents, acid-reducing drugs, selective serotonin reuptake inhibitors, and heparin. A number of drugs are known to cause bone loss, increase fracture risk, or both. These drugs should be used in the lowest dose necessary to achieve the desired benefit and for the shortest time necessary, but in many cases, long-term treatment is required. Effective countermeasures are available for some.

Entities:  

Keywords:  Bone loss; Glucocorticoids; Gonadotropin-releasing hormone

Mesh:

Substances:

Year:  2017        PMID: 28752332     DOI: 10.1007/s00198-017-4171-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  89 in total

Review 1.  Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis.

Authors:  N Veronese; G Bano; G Bertozzo; S Granziera; M Solmi; E Manzato; G Sergi; A T Cohen; C U Correll
Journal:  J Thromb Haemost       Date:  2015-08-10       Impact factor: 5.824

Review 2.  Best practice guidelines for the management of women with epilepsy.

Authors:  Pamela Crawford
Journal:  Epilepsia       Date:  2005       Impact factor: 5.864

Review 3.  Overview of elagolix for the treatment of endometriosis.

Authors:  Gian Benedetto Melis; Manuela Neri; Valentina Corda; Maria Elena Malune; Bruno Piras; Silvia Pirarba; Stefano Guerriero; Marisa Orrù; Maurizio Nicola D'Alterio; Stefano Angioni; Anna Maria Paoletti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-05       Impact factor: 4.481

4.  Bone health management in men undergoing ADT: examining enablers and barriers to care.

Authors:  A N Damji; K Bies; S M H Alibhai; J M Jones
Journal:  Osteoporos Int       Date:  2014-12-20       Impact factor: 4.507

5.  SSRI use and risk of fractures among perimenopausal women without mental disorders.

Authors:  Yi-han Sheu; Amy Lanteigne; Til Stürmer; Virginia Pate; Deborah Azrael; Matthew Miller
Journal:  Inj Prev       Date:  2015-06-25       Impact factor: 2.399

Review 6.  Basic understanding of gonadotropin-releasing hormone-agonist triggering.

Authors:  Robert F Casper
Journal:  Fertil Steril       Date:  2015-02-21       Impact factor: 7.329

7.  Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative.

Authors:  Laura D Carbone; Karen C Johnson; Andrew J Bush; John Robbins; Joseph C Larson; Asha Thomas; Andrea Z LaCroix
Journal:  Arch Intern Med       Date:  2009-01-26

8.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin.

Authors:  T C Dahlman
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

Review 10.  Advances in pharmacotherapy for treating endometriosis.

Authors:  Emanuela Tafi; Umberto Leone Roberti Maggiore; Franco Alessandri; Stefano Bogliolo; Barbara Gardella; Valerio Gaetano Vellone; Federica Grillo; Luca Mastracci; Simone Ferrero
Journal:  Expert Opin Pharmacother       Date:  2015-09-07       Impact factor: 3.889

View more
  4 in total

1.  Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.

Authors:  Pamela L Lutsey; Faye L Norby; Kristine E Ensrud; Richard F MacLehose; Susan J Diem; Lin Y Chen; Alvaro Alonso
Journal:  JAMA Intern Med       Date:  2020-02-01       Impact factor: 21.873

2.  Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study.

Authors:  Wolfgang Brozek; Berthold Reichardt; Jochen Zwerina; Hans Peter Dimai; Klaus Klaushofer; Elisabeth Zwettler
Journal:  Bone Rep       Date:  2019-04-01

Review 3.  Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature.

Authors:  Gaetano Caramori; Paolo Ruggeri; Fabio Arpinelli; Laura Salvi; Giuseppe Girbino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-23

Review 4.  Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management.

Authors:  Vasileios Patriarcheas; Antonios Pikoulas; Minas Kostis; Andriani Charpidou; Evangelos Dimakakos
Journal:  Cureus       Date:  2020-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.